Suspension of Nasdaq Minimum Bid Price Buys Nanogen More Time for Compliance

Oct 28, 2008

NEW YORK (GenomeWeb News) – Due to a recent suspension by Nasdaq of certain listing requirements, Nanogen now has until Feb. 26, 2009, to gain compliance with the exchange’s $1 minimum bid rule, the firm said in a filing with the US Securities and Exchange Commission yesterday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Faster Profiles

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

Standards Needed

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

Conflict Search

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

This Week in Science

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.

Main menu